DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact

Clinical trial NCT00789477 · COMPLETED

Trial details

NCT number: NCT00789477
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2008-12-01
Primary completion: 2009-12-01
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.